Market Analysis - Annual Report -April, 2020- Sulfamonomethoxine Sodium
Analyst : Steven
1.Overview of the Current Market Situation
In April 2020, the price of sulfamethoxine sodium generally remained stable, as follows
1.On the supply side, Henan Houyi Pharmaceutical Co.,Ltd. mainly delivered pre-orders in April. Domestic and foreign trade orders have been delivered one after another, and it is expected that the supply shortage will be eased in mid-May. The other two factorys, Jiangsu Tianhe Pharmaceutical Co.,Ltd. and Wujiang Bolin Industry Co.,Ltd. These price is higher than Houyi Pharmaceutical Co.,Ltd., and the delivery time is about one week.
2.On the market demand side, sulfamethoxine sodium is the main market in Vietnam,the weakening of demand in April was mainly due to the fact that most orders were in February and March. At present, customers in the Vietnamese market are mainly waiting for delivery.
3.The upstream supply of sulfamethoxine sodium is currently stable and there is no possibility of rising again.

2.Market Forecast for Next Month
In summary, it is expected that in May 2020, production and delivery at the factory will gradually become normal, the market has a large right to speak, and the factory has a small right to speak. The price is stable in May.
|
Factor |
Explanation |
|
Inventory |
Henan Houyi Pharmaceutical Co.,Ltd. currently does not have any inventory, and mainly focuses on pre-delivery orders. Jiangsu Tianhe Pharmaceutical Co.,Ltd. and Wujiang Bolin Industry Co.,Ltd. deliver fast. |
|
Market Demand |
The market demand is small, mainly affected by the epidemic and the purchase period of customers is concentrated in February and march. |
|
Factory Mentality |
Henan Houyi Pharmaceutical Co.,Ltd. currently has the best price and high cost performance. Currently Henan Houyi Pharmaceutical Co.,Ltd. is still executing pre-orders. It is expected to be available from stock in mid-May. |
|
Upstream Raw Materials |
Currently, the upstream raw material supply is stable. In the short term, the price of API does not have the possibility of a substantial increase. |
Looking for chemical products? Let suppliers reach out to you!
2026-06-24
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
-
Pharmaconex 2022
-
CPHI Korea 2022
-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitation, Original Research Drugs Soared 5527%
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
Industrialization Progress of genetically modified pharmaceutical products
-
2022 Top 50 Global Pharmaceutical Companies Released! Pfizer Returns to NO.1, Kexing Counterattack First on the List
-
Pharmaceutical and Health Industry Special Study - The Arrival of New Opportunities
-
Accelerate Technological Breakthroughs in Product Innovation and Promote the Industrialization and Application of Innovative Drugs
-
The Rare Disease Market Continues to Heat Up. How Will The Global Top 10 Pharmaceutical Companies by Revenue in 2021 be Deployed?
Recommend Reading
-
When Global Buyers No Longer Visit Trade Shows but “Select Suppliers with a Click”
-
When Global Buyers Sit at the Same Table, Chinese Suppliers Respond: A Real 1-on-1 Online Business Matching Event
-
On the Second Day of the 93rd API China: ECHEMI Advances Global Dialogue in the Pharmaceutical Industry Through Innovative Practices
-
Review of the 93rd API China: In Chongqing, Witnessing the Global Pulse of the Pharmaceutical Industry
-
From API China to the Global Pharmaceutical Chain: ECHEMI Is Reshaping the "New Speed" of Pharmaceutical Trade
-
Solvay's "Slimming Action": Soda Ash Production Capacity in Spain Slashed by 180,000 Tons, 77 Jobs to Go
-
This Week's Styrene Market Continues to Rise (1.26-1.30)
-
Polystyrene (PS): Properties, Foam Applications, and Recycling Challenges
-
Caustic Soda Prices Continue to Decline in January
-
Record Net Profit, Yet “Joining Forces” with a Rival? Axalta Drops a Final Trump Card Before the Merger